ArticleeNeurologicalSci2025
Parkinsonism in Gerstmann-Sträussler-Scheinker disease: A case report.
Article in eNeurologicalSci, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Autosomal dominant prion diseases of the central nervous system, including Gerstmann-Sträussler-Scheinker disease (GSS), Creutzfeldt-Jakob disease, and fatal familial insomnia, are caused by mutations in the PRNP gene. These conditions exhibit highly variable clinical and pathological features, making diagnosis challenging, with poor survival outcomes. In Colombia, the incidence of prion diseases remains unknown. We report a case of GSS with parkinsonism, a rare presentation, emphasizing intrafamilial variability with the same pathogenic variant, underscoring the importance of reporting each case. Case presentation: A 55-year-old woman from Colombia presented with symptoms of instability, rigidity, and bradykinesia. Over one year, her condition progressed to cognitive decline, dysphagia, and severe motor impairment. Differential diagnostic studies were conducted. A pathogenic P102L mutation in the PRNP gene was identified, confirming an autosomal dominant inheritance pattern. Symptomatic management and interdisciplinary rehabilitation were initiated. This mutation led to the diagnosis of at least 10 symptomatic family members and allowed for genetic counseling of asymptomatic relatives. Conclusions: This case of GSS with the P102L mutation demonstrates a late onset and rapid progression with atypical parkinsonism presentation, without ataxia, which is predominantly reported in previous cases. The familial segregation of this mutation highlights the importance of monitoring and following at-risk relatives. While the disease remains incurable, knowledge of genetic predisposition allows for better family planning and appropriate medical support, improving quality of life and emotional support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.